SETTING UP A PLAN IS AS

 

EASY AS

FREE
CONSULTATION

 

Describe your Employment Due Diligence goals and why they’re important to your Company

Policy
Recommendation

 

Strategize a Game Plan that will Target Your Goals

Implementation

 

Customize a Comprehensive Program that will Accomplish your Goals and Give you Peace of Mind

SETTING UP A PLAN IS AS
EASY AS

Free Consultation

 

DESCRIBE YOUR EMPLOYMENT DUE DILIGENCE GOALS AND WHY THEY'RE IMPORTANT TO YOUR COMPANY

Policy Recommendation

 

STRATEGIZE A GAME PLAN THAT WILL TARGET YOUR GOALS

Implementation

 

Customize a Comprehensive Program that will Accomplish your Goals and Give you Peace of Mind

News and Updates

Federal DOT Drug Testing Rule Changes

DOT UPDATES DRUG TESTING REQUIREMENTS

Effective January 1, 2018 — The Federal Department of Transportation (DOT) revised its drug testing program regulation to include detection for four semi-synthetic opioids: hydrocodone, hydromorphone, oxycodone and oxymorphone. In addition, methylenedioxyamphetamine (MDA) has been added as an initial test analyte, and methylenedioxyethylamphetamine (MDEA) has been removed as a confirmatory test analyte.
Federally Regulated DOT Drug Test Programs
Mandated changes take effect January 1, 2018, and apply to all Federally regulated DOT drug test programs. The regulations now harmonize testing with the Department of Health and Human Services (HHS) Mandatory Guidelines that were revised earlier this year.
The DOT has also made the decision to discontinue the practice of blind specimens, as the accuracy of HHS labs has consistently been established over the years. Therefore, Third Party Administrators (TPAs) will no longer be required to submit blind specimens on behalf of their clients.
For Regulated Testing – No Action Required
All regulated test profiles will be modified January 1, 2018. Contact your DDS representative about pricing.
For HHS/DOT ‘look-alike’ – Action Required
If you are using a HHS/DOT ‘look-alike’ panel today, contact your DDS representative if you would like to begin using the NEW ‘look-alike’ panel. The current ‘look-alike’ panel will not be automatically modified.

Oxymorphone is a potent schedule II opioid analgesic drug with an abuse liability similar to morphine and other schedule II opioids. Recently there has been an increase in the abuse of oxymorphone.

Oxycodone has euphoric effects similar to other opioids, oxycodone, and is one of the drugs abused in the current opioid epidemic in the United States.

Hydrocodone has a high risk for addiction and dependence. Can cause respiratory distress and death when taken in high doses or when combined with other substances, especially alcohol.

Hydromorphone has a high risk for addiction and dependence. Can cause respiratory distress and death when taken in high doses or when combined with other substances, especially alcohol.

Methylenedioxyamphetamine is an empathogen-entactogen, psychostimulant, and psychedelic drug of the amphetamine family that is encountered mainly as a recreational drug.




Account Login
Username:
Password:
Forgot Password?
 


DDS TEST DRIVE


Call for a no obligation strategy for your business today.800-647-7999